TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Paul Richardson, MD

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115

Dana Faber Cancer Institute


Boston, Massachusetts - 02115

Dana-Farber Cancer Institute/Brigham & Women's ...


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 5
  • CONDITIONS4
  • INTERVENTIONS7
  • SINCE2005
A Phase 1b/2 Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma

April 2008 - September 2011
MTD Safety and Efficacy of CC-4047 Alone With Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma

May 2008 - September 2011
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

January 2009 - November 2010
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

April 2005 - September 2011
Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

March 2007 - June 2009
Multiple Myeloma

Neoplasms, Plasma Cell

Bone Diseases

Hematologic Neoplasms

Placebo

Dexamethasone

Elotuzumab (Huluc63)

Cc-4047

Npi-0052

Bhq880

Dendritic Cell Tumor Fusion

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo